Year Established :
2001
Total Number of Staff :
100-500
Main Competitive Advantages :
Brand Name,International Approvals/Standards,Experienced R&D Staff,Production Capacity,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Reputation,Quality Service
Other Competitive Advantages :
- Strictly controlled and abundant uptream raw material ensure stable and sufficient supply
- State-owned company with high quality， independent QA&QC, skilled analyst, integrated quality management system, sophisticated document system.
- Global leading Vinca alkaloids oncology API provider
- Dedicated workshop avoid cross-contamination
- Professional cold chain logistics and transportation
- Customer-oriented, customized high quality standard product
Business Type :
Manufacturer
R&D Capacity :
Own Brand
Main Sales Markets :
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Product Range :
1. Oncology APIs: Vinorelbine tratrate, Vincristine sulfate, Vinblastine sulfate, Vindesine sulfate;
2. Excipients: Egg phospholipids, Soybean Oil for injection, Medium chain Triglycerides, Propyl Gallate.
Twelve years of qualification
Audited Supplier
Pharma Sources Insight JANUARY 2024
